Characteristics, determinants, and clinical relevance of CD4 T cell recovery to &lt;500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy

Kaufmann, G. R.; Furrer, Hansjakob; Ledergerber, Bruno; Perrin, Luc; Opravil, Milos; Vernazza, Pietro; Cavassini, Matthias; Bernasconi, Enos; Rickenbach, Martin; Hirschel, Bernard; Battegay, Manuel

doi:10.1086/431484

Advanced search

Browse by...

Deposit

Highlights

More informations

Title		Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy
Authors		Kaufmann, G. R. Furrer, Hansjakob Ledergerber, Bruno Perrin, Luc Opravil, Milos Vernazza, Pietro Cavassini, Matthias Bernasconi, Enos Rickenbach, Martin Hirschel, Bernard Battegay, Manuel show all authors [1 - 11]
Published in		Clinical infectious diseases. 2005, vol. 41, no. 3, p. 361-372
Abstract		BACKGROUND: The CD4 T cell count recovery in human immunodeficiency virus type 1 (HIV-1)-infected individuals receiving potent antiretroviral therapy (ART) shows high variability. We studied the determinants and the clinical relevance of incomplete CD4 T cell restoration. METHODS: Longitudinal CD4 T cell count was analyzed in 293 participants of the Swiss HIV Cohort Study who had had a plasma HIV-1 RNA load <1000 copies/mL for > or =5 years. CD4 T cell recovery was stratified by CD4 T cell count 5 years after initiation of ART (> or =500 cells/microL was defined as a complete response, and <500 cells/microL was defined as an incomplete response). Determinants of incomplete responses and clinical events were evaluated using logistic regression and survival analyses. RESULTS: The median CD4 T cell count increased from 180 cells/microL at baseline to 576 cells/microL 5 years after ART initiation. A total of 35.8% of patients were incomplete responders, of whom 47.6% reached a CD4 T cell plateau <500 cells/microL. Centers for Disease Control and Prevention HIV-1 disease category B and/or C events occurred in 21% of incomplete responders and in 14.4% of complete responders (P>.05). Older age (adjusted odds ratio [aOR], 1.71 per 10-year increase; 95% confidence interval [CI], 1.21-2.43), lower baseline CD4 T cell count (aOR, 0.37 per 100-cell increase; 95% CI, 0.28-0.49), and longer duration of HIV infection (aOR, 2.39 per 10-year increase; 95% CI, 1.19-4.81) were significantly associated with a CD4 T cell count <500 cells/microL at 5 years. The median increases in CD4 T cell count after 3-6 months of ART were smaller in incomplete responders (P<.001) and predicted, in conjunction with baseline CD4 T cell count and age, incomplete response with 80% sensitivity and 72% specificity. CONCLUSION: Individuals with incomplete CD4 T cell recovery to <500 cells/microL had more advanced HIV-1 infection at baseline. CD4 T cell changes during the first 3-6 months of ART already reflect the capacity of the immune system to replenish depleted CD4 T lymphocytes.
Keywords		Adult — Anti-HIV Agents/ therapeutic use — CD4 Lymphocyte Count — CD8-Positive T-Lymphocytes — Cohort Studies — Female — HIV Infections/ drug therapy — Humans — Logistic Models — Male — Middle Aged — Multivariate Analysis — Odds Ratio — RNA, Viral/blood — Risk Factors — Time Factors — Viral Load
Identifiers		DOI: 10.1086/431484 PMID: 16007534
Full text		Article - Limited access to UNIGE
Structures		Faculté de médecine / Section de médecine clinique / Département de médecine
Citation (ISO format)		KAUFMANN, G. R. et al. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. In: Clinical infectious diseases, 2005, vol. 41, n° 3, p. 361-372. doi: 10.1086/431484 https://archive-ouverte.unige.ch/unige:7371